We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
New Roche Test Identify Syphilis in Routine Samples and Donated Blood
Product News

New Roche Test Identify Syphilis in Routine Samples and Donated Blood

New Roche Test Identify Syphilis in Routine Samples and Donated Blood
Product News

New Roche Test Identify Syphilis in Routine Samples and Donated Blood


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "New Roche Test Identify Syphilis in Routine Samples and Donated Blood"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Roche has announced the market availability of the Elecsys® Syphilis immunoassay, a diagnostic test to help detect patients infected with syphilis in routine clinical practice and to make sure donated blood is not infected with syphilis.

Although most new syphilis cases occur in developing countries, syphilis has re-emerged as a health concern in a number of developed nations over the past decade. Designed for the emerging needs of clinical laboratories for reliable and efficient detection of this disease the test enhances Roche’s solutions portfolio in serology testing - the testing of antibodies formed as a response to an infection - and complements the most comprehensive offering for blood safety available on the market today.

“Every year 12 million people get infected with syphilis worldwide. To test for syphilis at the early stage is important when the disease is still curable and it is essential that blood donations are free of syphilis pathogens when given to patients,” said Roland Diggelmann, Chief Operating Officer of the Roche Diagnostics Division. “We strive for continual improvement to meet laboratories’ and blood banks’ evolving needs, expanding our menu offering and providing integrated solutions to improve testing reliability, safety and efficiency.”

Thanks to its high sensitivity, the test minimizes the likelihood of missing syphilis infections, enabling healthcare professionals in laboratories to efficiently run a single test within 18 minutes, ensuring the safe and timely supply of blood products.

Moreover, its high specificity facilitates a clear and consistent interpretation of results at all disease stages with a minimal need for re-testing, providing maximum efficiency gains for the laboratory and patient safety.

Advertisement